JP2025516321A5 - - Google Patents

Info

Publication number
JP2025516321A5
JP2025516321A5 JP2024564983A JP2024564983A JP2025516321A5 JP 2025516321 A5 JP2025516321 A5 JP 2025516321A5 JP 2024564983 A JP2024564983 A JP 2024564983A JP 2024564983 A JP2024564983 A JP 2024564983A JP 2025516321 A5 JP2025516321 A5 JP 2025516321A5
Authority
JP
Japan
Prior art keywords
nucleotide
dsrna agent
nucleotides
antisense strand
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024564983A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025516321A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/066573 external-priority patent/WO2023215805A1/en
Publication of JP2025516321A publication Critical patent/JP2025516321A/ja
Publication of JP2025516321A5 publication Critical patent/JP2025516321A5/ja
Pending legal-status Critical Current

Links

JP2024564983A 2022-05-05 2023-05-03 アクチン結合LIMタンパク質3(ABLIM3)iRNA剤組成物およびその使用方法 Pending JP2025516321A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202263338645P 2022-05-05 2022-05-05
US63/338,645 2022-05-05
US202263352573P 2022-06-15 2022-06-15
US63/352,573 2022-06-15
PCT/US2023/066573 WO2023215805A1 (en) 2022-05-05 2023-05-03 ACTIN-BINDING LIM PROTEIN 3 (ABLIM3) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF

Publications (2)

Publication Number Publication Date
JP2025516321A JP2025516321A (ja) 2025-05-27
JP2025516321A5 true JP2025516321A5 (cg-RX-API-DMAC7.html) 2026-05-14

Family

ID=88647223

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024564983A Pending JP2025516321A (ja) 2022-05-05 2023-05-03 アクチン結合LIMタンパク質3(ABLIM3)iRNA剤組成物およびその使用方法

Country Status (4)

Country Link
US (1) US20250283079A1 (cg-RX-API-DMAC7.html)
EP (1) EP4518871A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025516321A (cg-RX-API-DMAC7.html)
WO (1) WO2023215805A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12454693B1 (en) 2024-09-27 2025-10-28 Dexcel Pharma Technologies Ltd. Nucleic acids for inhibiting expression of transferrin receptor 2

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015138960A2 (en) * 2014-03-14 2015-09-17 The General Hospital Corporation Molecular re-engineering of excitation-inhibition balance in memory circuits
CA3052290A1 (en) * 2017-02-10 2018-08-16 The Rockefeller University Methods for cell-type specific profiling to identify drug targets
WO2020172343A2 (en) * 2019-02-19 2020-08-27 Massachusetts Institute Of Technology Methods for treating injuries

Similar Documents

Publication Publication Date Title
JP7805386B2 (ja) Lpa発現を阻害するための組成物及び方法
JP2022515193A5 (cg-RX-API-DMAC7.html)
TWI727963B (zh) 甲狀腺素運載蛋白(TTR)iRNA組成物及其治療或預防TTR相關疾病之使用方法
JP2023521604A5 (cg-RX-API-DMAC7.html)
JP2024041748A (ja) Angptl3発現を阻害する組成物及び方法
JP2023523993A5 (cg-RX-API-DMAC7.html)
JP2024536811A5 (cg-RX-API-DMAC7.html)
JP7830319B2 (ja) ハンチンチン(HTT)iRNA剤組成物およびその使用方法
KR20200078530A (ko) Ldha의 발현을 억제하기 위한 방법 및 조성물
JP2025179045A (ja) アンジオテンシノーゲン(AGT)iRNA組成物及びその使用方法
TW201726148A (zh) 治療serpinc1相關疾患之方法及組成物
CN113544272A (zh) Hsd17b13表达的调节剂
JP2024516356A (ja) ケトヘキソキナーゼ(khk)を阻害するための組成物及び方法
JP2024528503A5 (cg-RX-API-DMAC7.html)
JP2021059542A (ja) Reversir(商標)化合物
JP2023511434A5 (cg-RX-API-DMAC7.html)
JP7560616B2 (ja) 膜貫通型セリンプロテアーゼ6(tmprss6)発現を阻害するための組成物および方法
JP2023544413A5 (cg-RX-API-DMAC7.html)
JP2024522068A5 (cg-RX-API-DMAC7.html)
JP2024509783A5 (cg-RX-API-DMAC7.html)
IL294728A (en) lrrk2 RNA material preparations and methods of using them
BR112021012516A2 (pt) Composições e métodos para inibir a expressão de hmgb1
JP2025507372A5 (cg-RX-API-DMAC7.html)
JP2024521907A5 (cg-RX-API-DMAC7.html)
BR112021003609A2 (pt) produtos e composições